InvestorsObserver is giving ORIC Pharmaceuticals Inc (ORIC) an Analyst Rating Rank of 30, meaning ORIC is ranked higher by analysts than 30% of stocks. The average price target for ORIC is $13.666 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating ORIC a Buy today. Find out what this means to you and get the rest of the rankings on ORIC!